FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: Measure/example-IHE-QORE-Opioid-11

Packageihe.qrph.qore
Resource TypeMeasure
Idexample-IHE-QORE-Opioid-11
FHIR VersionR4
Sourcehttp://profiles.ihe.net/QRPH/QORE/https://build.fhir.org/ig/IHE/QRPH.QORE/Measure-example-IHE-QORE-Opioid-11.html
URLhttp://profiles.ihe.net/QRPH/QORE/Measure/example-IHE-QORE-Opioid-11
Version0.1.0
Statusunknown
Date2024-10-23T20:00:04+00:00
TitlePercentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration
Realmuv
Authorityihe
CopyrightIHE http://www.ihe.net/Governance/#Intellectual_Property

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: Measure example-IHE-QORE-Opioid-11

url: Measure Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration

version: 0.1.0

title: Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration

status: Unknown

date: 2024-10-23 20:00:04+0000

publisher: IHE Quality, Research and Public Health Committee

contact: https://www.ihe.net/ihe_domains/quality_research_and_public_health/, qrph@ihe.net, IHE Quality, Research and Public Health Committee: qrph@ihe.net

jurisdiction: Global (Whole world)

copyright:

IHE http://www.ihe.net/Governance/#Intellectual_Property

type: outcome

rationale:

Patients an opioid overdose may become agitated or violent following naloxone administration due to acute opioid withdrawal. Therefore, the goal is to use the lowest dose possible to restore spontaneous respirations but avoid precipitating withdrawal

definition:

Measures the percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration.

group

population

code: numerator

description: All patients who were given Narcan, and developed adverse effects.

Criteria

-Language
*CQL

population

code: denominator

description: All patients who were given Narcan.

Criteria

-Language
*CQL

Source

{
  "resourceType": "Measure",
  "id": "example-IHE-QORE-Opioid-11",
  "meta": {
    "security": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActReason",
        "code": "HTEST"
      }
    ]
  },
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "url": "http://profiles.ihe.net/QRPH/QORE/Measure/example-IHE-QORE-Opioid-11",
  "version": "0.1.0",
  "title": "Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration",
  "status": "unknown",
  "date": "2024-10-23T20:00:04+00:00",
  "publisher": "IHE Quality, Research and Public Health Committee",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "https://www.ihe.net/ihe_domains/quality_research_and_public_health/"
        }
      ]
    },
    {
      "telecom": [
        {
          "system": "email",
          "value": "qrph@ihe.net"
        }
      ]
    },
    {
      "name": "IHE Quality, Research and Public Health Committee",
      "telecom": [
        {
          "system": "email",
          "value": "qrph@ihe.net"
        }
      ]
    }
  ],
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code": "001"
        }
      ]
    }
  ],
  "copyright": "IHE http://www.ihe.net/Governance/#Intellectual_Property",
  "type": [
    {
      "coding": [
        {
          "code": "outcome"
        }
      ]
    }
  ],
  "rationale": "Patients an opioid overdose may become agitated or violent following naloxone administration due to acute opioid withdrawal. Therefore, the goal is to use the lowest dose possible to restore spontaneous respirations but avoid precipitating withdrawal",
  "definition": [
    "Measures the percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration."
  ],
  "group": [
    {
      "population": [
        {
          "code": {
            "coding": [
              {
                "code": "numerator"
              }
            ]
          },
          "description": "All patients who were given Narcan, and developed adverse effects.",
          "criteria": {
            "language": "text/cql"
          }
        },
        {
          "code": {
            "coding": [
              {
                "code": "denominator"
              }
            ]
          },
          "description": "All patients who were given Narcan.",
          "criteria": {
            "language": "text/cql"
          }
        }
      ]
    }
  ]
}